Clinical Trial Update: Renal Graft Function After Treatment With Erythropoietin (EPO) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating erythropoietin for renal graft function in the context of ischemia has been terminated. This document provides a status update on the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Ischemia | Phase 3 | Status: TERMINATED